A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN

NCT04949503 · clinicaltrials.gov ↗

COMPLETED

Status

1931

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: nimotuzumab

Sponsor

Biotech Pharmaceutical Co., Ltd.